Thailand
Tuberculosis profile
| High TB burden | High HIV burden |
Population  2012 67 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 9.2 (3.8–17) 14 (5.8–25)
Mortality (HIV+TB only) 2.2 (1.9–2.8) 3.3 (2.9–4.2)
Prevalence  (includes HIV+TB) 110 (47–190) 159 (71–282)
Incidence  (includes HIV+TB) 80 (66–95) 119 (98–142)
Incidence (HIV+TB only) 12 (10–14) 18 (15–22)
Case detection, all forms (%) 76 (64–92)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 30 998 (54) Relapse 1 887 (68)
Smear-negative 17 537 (31) Treatment after failure 327 (12)
Smear-unknown / not done     Treatment after default 577 (21)
Extrapulmonary 8 852 (15) Other    
Other          
Total new 57 387   Total retreatment 2 791  
           
Other (history unknown) 1 030        
Total new and relapse 59 274   Total cases notified 61 208  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.4    
Age < 15 117    
Laboratories 2012
Smear (per 100 000 population) 1.6
Culture (per 5 million population) 4.9
Drug susceptibility testing (per 5 million population) 1.3
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 85   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 78  
Retreatment 69  
TB/HIV 2012 Number (%)
TB patients with known HIV status 44 035 (72)
HIV-positive TB patients 5 807 (13)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 4 460 (77)
HIV-positive TB patients on antiretroviral therapy (ART) 3 591 (62)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 1.7 (1–2.6) 35 (28–42)
MDR-TB cases among notified pulmonary
TB cases
800 (480–1 200) 960 (780–1 200)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB     7 379
Laboratory-confirmed MDR-TB cases     492
Patients started on MDR-TB treatment      
Financing TB control 2013
National TB programme budget (US$ millions) 14
% Funded domestically 51%
% Funded internationally 37%
% Unfunded 11%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data